Hu, X T <br/><br/>
Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.  [electronic resource] 

 -  Synapse (New York, N.Y.)  Mar 1992 
 - 206-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-4476 
<br/><br/><label>Standard No.: </label>10.1002/syn.890100304  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine--pharmacology<br/>Animals<br/>Apomorphine--pharmacology<br/>Cerebral Ventricles--drug effects<br/>Corpus Striatum--drug effects<br/>Denervation<br/>Desipramine--pharmacology<br/>Dopamine--metabolism<br/>Electrophysiology--methods<br/>Ergolines--pharmacology<br/>Injections, Intraventricular<br/>Iontophoresis<br/>Male<br/>Membrane Potentials--drug effects<br/>Motor Activity--drug effects<br/>Multivariate Analysis<br/>Neurons--drug effects<br/>Oxidopamine--administration & dosage<br/>Quinpirole<br/>Rats<br/>Rats, Inbred Strains<br/>Receptors, Dopamine--drug effects<br/>Receptors, Dopamine D1<br/>Receptors, Dopamine D2<br/>Reference Values<br/>Substantia Nigra--drug effects